Skip to content

Clinical trials

Genetic Diseases, Inborn trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Country / region: Japan Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20121
20131
20151
20161
20172
20185
20192
20212
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting4
Recruiting4
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical6
Novo Nordisk A/S6
Genzyme, a Sanofi Company2
ModernaTX, Inc.2
Chiesi Farmaceutici S.p.A.1
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company1
PTC Therapeutics1
Pfizer1
Shire1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn21
Achondroplasia6
Musculoskeletal Diseases6
Bone Diseases5
Osteochondrodysplasias5
Bone Diseases, Developmental4
Dwarfism4
Blood Coagulation Disorders3
Blood Coagulation Disorders, Inherited3
Coagulation Protein Disorders3

Trials

Showing 76 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.